Home » Newsletters » BioWorld Science

BioWorld Science

June 27, 2001

View Archived Issues

BAIPs with broad-spectrum anti-HIV activity available for licensing from NIH

Combination of PDE4 and PDE3 inhibitors for Th1-mediated autoimmune diseases

Johnson & Johnson/Alza complete merger

EntreMed and Aventis establish collaborative agreement for phase II prostate cancer trial

Pivotal data reported for Xanelim in psoriasis

Modulation of mitochondrial metabolism as a novel treatment strategy for type 2 diabetes

Potent and selective glucagon receptor antagonist as potential new therapy for type 2 diabetes

Genelabs' NDA for Aslera deemed unapprovable by FDA

Maxia designs molecule with antidiabetic and antidyslipidemic effects

Vion's sulfonylhydrazine prodrug enters phase I evaluation

TBC-1269 enters clinical evaluation as inhaled therapy for asthma

Cellegy files NDA for Anogesic; completes enrollment in second phase III trial

Novuspharma's IND for BBR-2778 accepted by FDA

Selective activation of pancreatic beta-cell K(ATP) channel achieved by diazoxide analogue

Symbollon announces plans for phase III IoGen trials; completes name change

Health Canada approves Levulan Kerastick

ADA news: Telik designs orally active insulin receptor tyrosine kinase activator

Versicor initiates phase II study of novel antifungal agent for invasive candidiasis/candidemia

Positive phase I results reported for Active Biotech's TTS

Novel class of therapeutics for type 2 diabetes: small-molecule glucokinase activators

Vasogen completes patient enrollment in congestive heart failure trial

Inhibitors of beta-amyloid peptide production or release discovered at Lilly

New Aventis compounds useful as anticoagulants for thrombotic disorders

Japanese pharmaceutical company presents new hypoglycemic agents

Stable GLP-1 analogue with enhanced in vivo efficacy: BIM-51077

Antiviral agents active against HSV-1 patented by Toagosei

Sankyo designs dihydroquinoline ileal bile acid transport inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...